BCL2L1 and carcinoma: Furthermore, the expression of the anti-apoptotic BCLXL was significantly reduced, while the expression of the apoptotic protein CD95 was significantly elevated in GATA6high carcinoma ROIs (Figure 6I; p.adj = 0.02 and p.adj = 0.03, respectively).